Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学HNSCC Radiotherapy, Immunotherapy

Kevin Harrington

MBBS, PhD, FRCP, FRCR

🏢Royal Marsden Hospital / Institute of Cancer Research🌐UK

Professor of Biological Cancer Therapy

65
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Kevin Harrington at the Royal Marsden and Institute of Cancer Research is a leading translational scientist and clinician in HNSCC with expertise in combining radiotherapy, immunotherapy, and novel biologics. He has led major trials of immunotherapy combined with chemoradiation in locally advanced HNSCC including studies of avelumab, durvalumab, and oncolytic viruses. His laboratory investigates radiobiology and immune activation in head and neck tumors. He has been a key opinion leader in UK and global HNSCC treatment guidelines.

Share:

🧪Research Fields 研究领域

HNSCC radiotherapy
immunotherapy HNSCC combination
oncolytic virus HNSCC
HPV+ oropharyngeal treatment
concurrent chemoradiation HNSCC

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Kevin Harrington 的研究动态

Follow Kevin Harrington's research updates

留下邮箱,当我们发布与 Kevin Harrington(Royal Marsden Hospital / Institute of Cancer Research)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment